Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen antigens and toxins represent a diverse group of molecules derived from infectious agents, including bacteria, viruses, fungi, and parasites, that elicit an immune response or cause direct damage to host tissues (NIH, 2022). Antigens are typically surface-exposed proteins or polysaccharides that serve as the primary targets for vaccines and therapeutic antibodies, facilitating pathogen recognition and clearance by the immune system (CDC, 2023). Toxins are specialized virulence factors, such as exotoxins or endotoxins, that disrupt host cellular processes, often leading to severe clinical manifestations like sepsis or organ failure (StatPearls, 2023). In drug development, these molecules are targeted to prevent infection through prophylaxis or to neutralize harmful effects during an active disease state using monoclonal antibodies like bezlotoxumab or raxibacumab (FDA, 2023). Because this category encompasses a vast array of structurally distinct molecules, therapeutic strategies vary widely, ranging from small molecule inhibitors of toxin activity to complex biologicals that mimic or enhance the host's natural defenses (PubMed, 2021). Monitoring these targets often involves measuring antigen or toxin levels in blood or tissue to guide treatment efficacy and patient selection (WHO, 2022).
Neutralization of biological activity, inhibition of host cell binding, and induction of adaptive immune responses.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen antigens and toxins.